Cargando…

Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome

OBJECTIVE: Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES. DESIGN: 70 patients with severe PRES admitted to 24 ICUs in 2001–2010 were included in a retrospective cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Legriel, Stephane, Schraub, Olivier, Azoulay, Elie, Hantson, Philippe, Magalhaes, Eric, Coquet, Isaline, Bretonniere, Cedric, Gilhodes, Olivier, Anguel, Nadia, Megarbane, Bruno, Benayoun, Laurent, Schnell, David, Plantefeve, Gaetan, Charpentier, Julien, Argaud, Laurent, Mourvillier, Bruno, Galbois, Arnaud, Chalumeau-Lemoine, Ludivine, Rivoal, Michel, Durand, François, Geffroy, Arnaud, Simon, Marc, Stoclin, Annabelle, Pallot, Jean-Louis, Arbelot, Charlotte, Nyunga, Martine, Lesieur, Olivier, Troché, Gilles, Bruneel, Fabrice, Cordoliani, Yves-Sébastien, Bedos, Jean-Pierre, Pico, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443081/
https://www.ncbi.nlm.nih.gov/pubmed/23024751
http://dx.doi.org/10.1371/journal.pone.0044534
_version_ 1782243516192129024
author Legriel, Stephane
Schraub, Olivier
Azoulay, Elie
Hantson, Philippe
Magalhaes, Eric
Coquet, Isaline
Bretonniere, Cedric
Gilhodes, Olivier
Anguel, Nadia
Megarbane, Bruno
Benayoun, Laurent
Schnell, David
Plantefeve, Gaetan
Charpentier, Julien
Argaud, Laurent
Mourvillier, Bruno
Galbois, Arnaud
Chalumeau-Lemoine, Ludivine
Rivoal, Michel
Durand, François
Geffroy, Arnaud
Simon, Marc
Stoclin, Annabelle
Pallot, Jean-Louis
Arbelot, Charlotte
Nyunga, Martine
Lesieur, Olivier
Troché, Gilles
Bruneel, Fabrice
Cordoliani, Yves-Sébastien
Bedos, Jean-Pierre
Pico, Fernando
author_facet Legriel, Stephane
Schraub, Olivier
Azoulay, Elie
Hantson, Philippe
Magalhaes, Eric
Coquet, Isaline
Bretonniere, Cedric
Gilhodes, Olivier
Anguel, Nadia
Megarbane, Bruno
Benayoun, Laurent
Schnell, David
Plantefeve, Gaetan
Charpentier, Julien
Argaud, Laurent
Mourvillier, Bruno
Galbois, Arnaud
Chalumeau-Lemoine, Ludivine
Rivoal, Michel
Durand, François
Geffroy, Arnaud
Simon, Marc
Stoclin, Annabelle
Pallot, Jean-Louis
Arbelot, Charlotte
Nyunga, Martine
Lesieur, Olivier
Troché, Gilles
Bruneel, Fabrice
Cordoliani, Yves-Sébastien
Bedos, Jean-Pierre
Pico, Fernando
author_sort Legriel, Stephane
collection PubMed
description OBJECTIVE: Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES. DESIGN: 70 patients with severe PRES admitted to 24 ICUs in 2001–2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90. MAIN RESULTS: Consciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures occurred in 57 (81%) patients. Median mean arterial pressure was 122 (105–143) mmHg on scene. Cerebral imaging abnormalities were bilateral (93%) and predominated in the parietal (93%) and occipital (86%) white matter. Median number of brain areas involved was 4 (3–5). Imaging abnormalities resolved in 43 (88%) patients. Ischaemic and/or haemorrhagic complications occurred in 7 (14%) patients. The most common causes were drug toxicity (44%) and hypertensive encephalopathy (41%). On day 90, 11 (16%) patients had died, 26 (37%) had marked functional impairments (GOS, 2 to 4), and 33 (56%) had a good recovery (GOS, 5). Factors independently associated with GOS<5 were highest glycaemia on day 1 (OR, 1.22; 95%CI, 1.02–1.45, p = 0.03) and time to causative-factor control (OR, 3.3; 95%CI, 1.04–10.46, p = 0.04), whereas GOS = 5 was associated with toxaemia of pregnancy (preeclampsia/eclampsia) (OR, 0.06; 95%CI, 0.01–0.38, p = 0.003). CONCLUSIONS: By day 90 after admission for severe PRES, 44% of survivors had severe functional impairments. Highest glycaemia on day 1 and time to causative-factor control were strong early predictors of outcomes, suggesting areas for improvement.
format Online
Article
Text
id pubmed-3443081
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34430812012-09-28 Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome Legriel, Stephane Schraub, Olivier Azoulay, Elie Hantson, Philippe Magalhaes, Eric Coquet, Isaline Bretonniere, Cedric Gilhodes, Olivier Anguel, Nadia Megarbane, Bruno Benayoun, Laurent Schnell, David Plantefeve, Gaetan Charpentier, Julien Argaud, Laurent Mourvillier, Bruno Galbois, Arnaud Chalumeau-Lemoine, Ludivine Rivoal, Michel Durand, François Geffroy, Arnaud Simon, Marc Stoclin, Annabelle Pallot, Jean-Louis Arbelot, Charlotte Nyunga, Martine Lesieur, Olivier Troché, Gilles Bruneel, Fabrice Cordoliani, Yves-Sébastien Bedos, Jean-Pierre Pico, Fernando PLoS One Research Article OBJECTIVE: Few outcome data are available about posterior reversible encephalopathy syndrome (PRES). We studied 90-day functional outcomes and their determinants in patients with severe PRES. DESIGN: 70 patients with severe PRES admitted to 24 ICUs in 2001–2010 were included in a retrospective cohort study. The main outcome measure was a Glasgow Outcome Scale (GOS) of 5 (good recovery) on day 90. MAIN RESULTS: Consciousness impairment was the most common clinical sign, occurring in 66 (94%) patients. Clinical seizures occurred in 57 (81%) patients. Median mean arterial pressure was 122 (105–143) mmHg on scene. Cerebral imaging abnormalities were bilateral (93%) and predominated in the parietal (93%) and occipital (86%) white matter. Median number of brain areas involved was 4 (3–5). Imaging abnormalities resolved in 43 (88%) patients. Ischaemic and/or haemorrhagic complications occurred in 7 (14%) patients. The most common causes were drug toxicity (44%) and hypertensive encephalopathy (41%). On day 90, 11 (16%) patients had died, 26 (37%) had marked functional impairments (GOS, 2 to 4), and 33 (56%) had a good recovery (GOS, 5). Factors independently associated with GOS<5 were highest glycaemia on day 1 (OR, 1.22; 95%CI, 1.02–1.45, p = 0.03) and time to causative-factor control (OR, 3.3; 95%CI, 1.04–10.46, p = 0.04), whereas GOS = 5 was associated with toxaemia of pregnancy (preeclampsia/eclampsia) (OR, 0.06; 95%CI, 0.01–0.38, p = 0.003). CONCLUSIONS: By day 90 after admission for severe PRES, 44% of survivors had severe functional impairments. Highest glycaemia on day 1 and time to causative-factor control were strong early predictors of outcomes, suggesting areas for improvement. Public Library of Science 2012-09-14 /pmc/articles/PMC3443081/ /pubmed/23024751 http://dx.doi.org/10.1371/journal.pone.0044534 Text en © 2012 Legriel et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Legriel, Stephane
Schraub, Olivier
Azoulay, Elie
Hantson, Philippe
Magalhaes, Eric
Coquet, Isaline
Bretonniere, Cedric
Gilhodes, Olivier
Anguel, Nadia
Megarbane, Bruno
Benayoun, Laurent
Schnell, David
Plantefeve, Gaetan
Charpentier, Julien
Argaud, Laurent
Mourvillier, Bruno
Galbois, Arnaud
Chalumeau-Lemoine, Ludivine
Rivoal, Michel
Durand, François
Geffroy, Arnaud
Simon, Marc
Stoclin, Annabelle
Pallot, Jean-Louis
Arbelot, Charlotte
Nyunga, Martine
Lesieur, Olivier
Troché, Gilles
Bruneel, Fabrice
Cordoliani, Yves-Sébastien
Bedos, Jean-Pierre
Pico, Fernando
Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome
title Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome
title_full Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome
title_fullStr Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome
title_full_unstemmed Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome
title_short Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome
title_sort determinants of recovery from severe posterior reversible encephalopathy syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443081/
https://www.ncbi.nlm.nih.gov/pubmed/23024751
http://dx.doi.org/10.1371/journal.pone.0044534
work_keys_str_mv AT legrielstephane determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT schraubolivier determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT azoulayelie determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT hantsonphilippe determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT magalhaeseric determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT coquetisaline determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT bretonnierecedric determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT gilhodesolivier determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT anguelnadia determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT megarbanebruno determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT benayounlaurent determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT schnelldavid determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT plantefevegaetan determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT charpentierjulien determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT argaudlaurent determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT mourvillierbruno determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT galboisarnaud determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT chalumeaulemoineludivine determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT rivoalmichel determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT durandfrancois determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT geffroyarnaud determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT simonmarc determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT stoclinannabelle determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT pallotjeanlouis determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT arbelotcharlotte determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT nyungamartine determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT lesieurolivier determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT trochegilles determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT bruneelfabrice determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT cordolianiyvessebastien determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT bedosjeanpierre determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome
AT picofernando determinantsofrecoveryfromsevereposteriorreversibleencephalopathysyndrome